home / stock / ogn / ogn news


OGN News and Press, Organon & Co. From 07/05/23

Stock Information

Company Name: Organon & Co.
Stock Symbol: OGN
Market: NYSE
Website: organon.com

Menu

OGN OGN Quote OGN Short OGN News OGN Articles OGN Message Board
Get OGN Alerts

News, Short Squeeze, Breakout and More Instantly...

OGN - Celltrion launches biosimilar of AbbVie's Humira in US

2023-07-05 12:57:34 ET South Korea's Celltrion ( OTC:CONIF ) has launched a high-concentration, citrate-free formulated biosimilar of AbbVie's ( NYSE: ABBV ) Humira in the US. The biosimilar, which is called Yuflyma, was approved by the FDA in May. Yuflyma's list price is $6...

OGN - Daré Bioscience Provides Update on Activities to Support Commercial Launch of XACIATO(TM) (clindamycin phosphate) vaginal gel, 2%, FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reaffirmed its commitment to the commercial launch of XACIATO [zah-she-AH-toe] (clindamycin phosphate) vaginal gel, 2% with collaborator Organon (NYSE: OGN),...

OGN - REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA(TM) (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system ...

OGN - Lilly, Vertex top pharma performers in H1; Moderna, Pfizer the worst

2023-07-01 16:00:00 ET Buoyed by booming sales of its diabetes drugs, Eli Lilly ( NYSE: LLY ) was the best performing large pharma or biotech in H1 2023, returning an impressive 28% . Coming in second, Vertex Pharmaceuticals ( VRTX ), helped by continued strong revenue f...

OGN - Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA(TM) (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system ...

OGN - Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks

2023-06-29 06:52:00 ET Whether you're saving for retirement, want to set aside money for travel, or just want to give yourself a raise, dividend stocks can help give you some extra income to accomplish those goals. Plus, by investing in quality stocks, you can also potentially profit from t...

OGN - Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent

2023-06-29 05:02:34 ET For further details see: Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent

OGN - Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

Second annual report highlights company’s advancements with a focus on innovation and access to ensure a healthier, more sustainable future for women worldwide. Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Envir...

OGN - Debt Metrics: How To Interpret Them And When They Matter

2023-06-08 12:39:22 ET Summary The article discusses leverage ratios such as debt to assets, debt to equity, debt to EBITDA, and debt to free cash flow, as well as the interest coverage ratio. Using company examples, I explain various definitions, when the individual metrics are b...

OGN - Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women's Health

Agreement is part of a transformative model convening governments, global development banks and other multilateral agencies to use results-based financing to improve the lives of women Today, Organon (NYSE:OGN), a global healthcare company focused on women’s health, and CAF, ...

Previous 10 Next 10